SHTDF OTC
Sinopharm Group Co. Ltd.
1W: -10.1%
1M: -13.0%
3M: -12.2%
YTD: -28.1%
1Y: -16.9%
3Y: -28.9%
5Y: -19.4%
$1.87
+0.04 (+2.41%)
Weekly Expected Move ±12.4%
$1
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$390.6B
-0.6% ▼
5Y CAGR: +4.6%
Total Liabilities
$256.3B
-3.7% ▼
5Y CAGR: +3.0%
Shareholders Equity
$84.0B
+6.5% ▲
5Y CAGR: +8.3%
Cash & Investments
$61.6B
+13.4% ▲
5Y CAGR: +4.2%
Total Debt
$108.6B
+42.2% ▲
5Y CAGR: +9.7%
Net Debt
$47.0B
+113.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $43.5B | $55.2B | $63.8B | $54.3B | $61.6B |
| Short-Term Investments | $12M | $498K | $547K | $158K | $129K |
| Cash & ST Investments | $43.5B | $55.2B | $63.8B | $54.3B | $61.6B |
| Net Receivables | $172.6B | $171.2B | $185.8B | $206.7B | $206.8B |
| Inventory | $51.5B | $60.9B | $60.0B | $62.4B | $63.4B |
| Other Current Assets | $13.4B | $16.6B | $16.2B | $14.0B | $15.2B |
| Total Current Assets | $290.9B | $319.4B | $336.8B | $347.4B | $347.0B |
| Property, Plant & Equip. | $17.6B | $17.8B | $19.9B | $19.6B | $18.2B |
| Goodwill & Intangibles | $12.2B | $12.0B | $10.0B | $11.0B | $8.2B |
| Long-Term Investments | $9.2B | $9.8B | $10.6B | $10.9B | $11.8B |
| Other Non-Current Assets | $3.7B | $3.7B | $6.1B | $1.5B | $2.5B |
| Total Non-Current Assets | $44.5B | $45.4B | $46.6B | $45.4B | $43.6B |
| Total Assets | $335.4B | $364.8B | $383.4B | $392.8B | $390.6B |
| — Liabilities — | |||||
| Accounts Payable | $132.9B | $144.6B | $154.7B | $156.9B | $112.7B |
| Short-Term Debt | $55.2B | $53.0B | $54.7B | $62.7B | $102.5B |
| Deferred Revenue | $21.6B | $0 | $0 | $0 | $6.0B |
| Other Current Liabilities | -$3.9B | $22.0B | $17.5B | $16.6B | $24.0B |
| Total Current Liabilities | $219.3B | $235.0B | $241.5B | $250.4B | $246.9B |
| Long-Term Debt | $8.4B | $11.8B | $13.8B | $8.6B | $3.6B |
| Other Non-Current Liab. | $3.3B | $3.4B | $3.1B | $3.9B | $2.7B |
| Total Non-Current Liabilities | $16.5B | $19.7B | $21.6B | $15.8B | $9.5B |
| Total Liabilities | $235.8B | $254.7B | $263.1B | $266.1B | $256.3B |
| — Equity — | |||||
| Common Stock | $3.1B | $3.1B | $3.1B | $3.1B | $3.1B |
| Retained Earnings | $38.5B | $42.9B | $49.4B | $53.7B | $58.8B |
| Accumulated OCI | -$4.4B | -$4.4B | $0 | $22.0B | $0 |
| Total Stockholders Equity | $61.9B | $68.1B | $74.6B | $78.9B | $84.0B |
| Total Liabilities & Equity | $335.4B | $364.8B | $383.4B | $392.8B | $390.6B |
| — Key Metrics — | |||||
| Total Debt | $68.4B | $69.6B | $73.8B | $76.4B | $108.6B |
| Net Debt | $24.8B | $14.4B | $10.0B | $22.1B | $47.0B |
| Total Investments | $9.2B | $9.8B | $10.6B | $10.9B | $11.8B |